Vertex Pharmaceuticals(us:VRTX)

    400.76

    +0.88%

    Updated on 2024-12-23

    Open:391.87
    Close:400.76
    High:402.69
    Low:391.00
    Pre Close:397.27
    Volume:1.15M
    Amount:457.29M
    Turnover:0.45%
    Shares:257.53M
    MarketCap:103.21B

    About Vertex Pharmaceuticals Company

    Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

    Company Name: Vertex Pharmaceuticals
    Company Address: 50 Northern Avenue
    Employees: 5400
    Fiscar Year: 12-31
    IPO Date: 1991-07-04
    CIK: 875320

    View all SEC Filings

    About

    Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
    Address:50 Northern Avenue

    Market Movers